Dynavox vd: "Exakt vad vi vill göra"

Yes, not for Sinch but for Dynavox we have had a good quarter. Um, you should see it in the light of the fact that we had a very strong quarter the same quarter last year. Then we grew by 38% but on top of that we grew this quarter by 16% as well.

And it is of course super fun to see that our business continues to chug along. But what is perhaps even more exciting is that we more than double the operating profit and operating result in this quarter and we double cash flow. So this is a business that not only, as we have proven for quite some time, grows very strongly on the top line globally, but we are now really getting this through on the bottom line.

Yes, so scalability in my world refers to growing revenue well but growing profitability even faster. And that is exactly what we show. We have as said a revenue growth in local currencies of 16% but a profit growth of 137% at the same time. And that is in my book exactly what we want to do. And we have also predicted that we would do. We have invested quite a lot to achieve this because this is about building a group and a company where everything is automated where not every new incoming krona should have to become an additional cost krona. Um, so we are very proud and then it is also very fun that this not only leads to a reported operating profit but this translates into kronor and ören in the bank account. That is, with more than doubled cash flow. That is where in my book at least you separate the wheat from the chaff. So we are very very satisfied with that.

Yes, no but 90% of our revenues are as you say paid by a public or private health insurance system somewhere in the world. And that means there are almost no fluctuations related to the economy or such. And they are also very strong payers. Um, but you are absolutely right that the penetration is vanishingly low and this is morally frustrating that there are so many millions of people out there who cannot communicate. We obviously have the solutions for them but they do not get them. Um, we drive this by educating the world. Um, to tell that this exists, if you have a child or a relative or you yourself do not have the ability to do it yourself, then there are aids out there. That is what also goes a bit slowly. Um, we work from lobbying to education to driving health economic studies so that not only is this morally right. We can also prove that quality of life increases by 65% in the latest case. But perhaps even more is that for every tax krona invested in this type of aid, society gets back over 3 kronor. That is, this is good for business too, and we feel that it is a very good offer to have, right?

No, it has probably not gotten better, rather one of the things we fight with besides what I mentioned earlier about education is also to grind through the bureaucracy, paperwork and so on to get these types of products prescribed because it is a speech therapist, occupational therapist or something that prescribes this. And their work has absolutely not become easier. Um, but at the same time we have become better at handling it. Um, I would say that it fluctuates and it is not like a story in every state, city, or country, but quite often part of what we struggle with is to get the prescription process to go as fast as possible. We do not experience that it is going faster right now, rather it is more bureaucracy. But it should still be seen in the light that there are no law changes, no proposed law changes. There are no countries that say we should stop paying for this type of aid, on the contrary, we see a bit more fluctuations. Sometimes it goes faster and sometimes it goes slower. We are currently experiencing, especially in North America, that it is going a little slower overall. Um, so no improvement, but also no crisis.

Yes, this is something we have done in the US. Um, and it is against a company called Ablenet which in our book, partly without permission and actually sells products that contain our software and so on without having permission from us, and moreover risks in our book to like throw a wrench in the works for the prescription process. Um, to create a bit of what we talked about earlier, to make the bureaucracy perhaps even more difficult. We have for quite some time tried to work with this company and explained that this is not how you do it. Um, but since we have been talking to deaf ears, we chose to sue them in May. Um, and this is of course nothing you like to do. But we believe it is absolutely right for us to defend not only our own business but actually the entire industry against what we consider actors who do not follow the rules of the game.

Yes. No but the cost is not monumental in this, we take costs for this ongoing and we experience that this is money that we have within our financial envelope. So it is nothing that makes us need to change our outlook or anything like that. It is of course what a win means in a legal process. Yes, you never really know. But it is really two things. One is that we assess that there are businesses that reasonably should have been ours. That is, an increased earning capacity or more business that rightfully should have been ours that has ended up in other hands. But also, just as you say, to ensure that actors do not destroy patients' ability to get access to this type of aid. That is, we want to remove what we assess as behavior that does not really follow the rulebook.